There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

Comments

Comment on this article

Cited by 2

Pediatric hepatocellular carcinoma: challenges and solutions
Authors: Irene Schmid, Dietrich von Schweinitz
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
Authors: Hamdy Azim, Ashraf Omar, Hesham Atef …

See all cited by

Sorafenib (S) alone versus S combined with gemcitabine and oxaliplatin (GEMOX) in first-line treatment of advanced hepatocellular carcinoma (HCC): Final analysis of the randomized phase II GONEXT trial (UNICANCER/FFCD PRODIGE 10 trial)

Read this article at

Related collections

Alternative approaches to Alzheimer's Disease

Comments

Comment on this article

Similar content 2,977

Cited by 2